MediBIC Group, established in 2000 and publicly listed in 2003, offers project planning, IRB, and data analysis services to support drug discovery and development for personalized medicine. They focus on the Health Care and Therapeutics industries and have invested in startups such as Intradigm Corporation. While their main office is in Tokyo, they frequently invest in the United States. The fund typically invests in startups that are 6-10 years old and participates in rounds with 8 other investors. Notable sponsors for the fund include Novartis Venture Fund and Frazier Healthcare Partners. MediBIC Group had a significant number of exits in 2009 and typically engages in less than 2 deals per year, with deal sizes ranging from 10 to 50 million dollars.